These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20871492)

  • 21. Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain.
    Wu N; Chen S; Boulanger L; Fraser K; Bledsoe SL; Zhao Y
    J Med Econ; 2009 Sep; 12(3):192-202. PubMed ID: 19705975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of mental health utilization and costs among children in a privately insured population.
    Leslie DL; Rosenheck RA; Horwitz SM
    Health Serv Res; 2001 Apr; 36(1 Pt 1):113-27. PubMed ID: 11324739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative cost analysis of outpatient and inpatient rehabilitation for cardiac diseases].
    Zeidler J; Mittendorf T; Vahldiek G; von der Schulenburg JM
    Herz; 2008 Sep; 33(6):440-7. PubMed ID: 19156379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The economic consequences of irritable bowel syndrome: a US employer perspective.
    Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ
    Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospitalization cost of congenital syphilis diagnosis from insurance claims data in the United States.
    Owusu-Edusei K; Introcaso CE; Chesson HW
    Sex Transm Dis; 2013 Mar; 40(3):226-9. PubMed ID: 23407468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States.
    Ivanova JI; Birnbaum HG; Kidolezi Y; Qiu Y; Mallett D; Caleo S
    Epilepsia; 2010 May; 51(5):838-44. PubMed ID: 20002150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database.
    Joish VN; Donaldson G; Stockdale W; Oderda GM; Crawley J; Sasane R; Joshua-Gotlib S; Brixner DI
    Curr Med Res Opin; 2005 Apr; 21(4):535-44. PubMed ID: 15899102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct medical costs for patients seeking emergency care for losses of epilepsy control in a U.S. managed care setting.
    Zachry WM; Doan QD; Smith BJ; Clewell JD; Griffith JM
    Epilepsy Behav; 2009 Oct; 16(2):268-73. PubMed ID: 19747882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The health and economic burden of genital warts in a set of private health plans in the United States.
    Insinga RP; Dasbach EJ; Myers ER
    Clin Infect Dis; 2003 Jun; 36(11):1397-403. PubMed ID: 12766834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The economic implications of treating atherothrombotic disease in Australia, from the government perspective.
    Ademi Z; Liew D; Hollingsworth B; Wolfe R; Steg GP; Bhatt DL; Reid CM;
    Clin Ther; 2010 Jan; 32(1):119-32; discussion 106-7. PubMed ID: 20171418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
    Davis KL; Candrilli SD; Edin HM
    Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US.
    Kim MH; Lin J; Kreilick C
    Adv Ther; 2009 Aug; 26(8):784-94. PubMed ID: 19690820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimated cost of treating myasthenia gravis in an insured U.S. population.
    Guptill JT; Sharma BK; Marano A; Soucy A; Krueger A; Sanders DB
    Muscle Nerve; 2012 Mar; 45(3):363-6. PubMed ID: 22334170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct medical costs of constipation in the United States.
    Martin BC; Barghout V; Cerulli A
    Manag Care Interface; 2006 Dec; 19(12):43-9. PubMed ID: 17274481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The functionality and economic costs of outpatients with schizophrenia in Taiwan.
    Lee IH; Chen PS; Yang YK; Liao YC; Lee YD; Yeh TL; Yeh LL; Cheng SH; Chu CL
    Psychiatry Res; 2008 Apr; 158(3):306-15. PubMed ID: 18243334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs of severely ill members and specialty medication use in a commercially insured population.
    Willey VJ; Pollack MF; Lednar WM; Yang WN; Kennedy C; Lawless G
    Health Aff (Millwood); 2008; 27(3):824-34. PubMed ID: 18474976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
    Asche CV; Joish VN; Camacho F; Drake CL
    Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost of dental services provided in private general practice for an insured population in New South Wales, Australia.
    Sivaneswaran S; Taylor R; Lazarus R
    Community Dent Health; 2000 Dec; 17(4):246-53. PubMed ID: 11191200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vesicoureteral reflux and ureteroceles.
    Pohl HG; Joyce GF; Wise M; Cilento BG
    J Urol; 2007 May; 177(5):1659-66. PubMed ID: 17437779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.